Jiajie Shi

No. 169 Tianshan Street
Shijiazhuang, 050011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Timing of multiple primary malignancies does not affect overall survival in lymphoma patients: a comparative study of 167 synchronous vs. metachronous cases.

Timing of multiple primary malignancies does not affect overall survival in lymphoma patients: a comparative study of 167 synchronous vs. metachronous cases.

Journal: American journal of cancer research

Published: April 16, 2026

Identification of gut microbes related molecular subtypes and prognostic markers in breast cancer.

Identification of gut microbes related molecular subtypes and prognostic markers in breast cancer.

Journal: Computer methods in biomechanics and biomedical engineering

Published: November 18, 2025

Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients.

Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: August 22, 2025

Machine learning-based histopathological features of histological slides and clinical characteristics as a novel prognostic indicator in diffuse large B-cell lymphoma.

Machine learning-based histopathological features of histological slides and clinical characteristics as a novel prognostic indicator in diffuse large B-cell lymphoma.

Journal: Pathology, research and practice

Published: April 16, 2025

Gut microbiota is associated with the disease characteristics of patients with newly diagnosed diffuse large B-cell lymphoma.

Gut microbiota is associated with the disease characteristics of patients with newly diagnosed diffuse large B-cell lymphoma.

Journal: American journal of cancer research

Published: April 07, 2025

The LncRNA RMST-miR-4295-ITPR1 axis: a key mechanism in regulating autophagy in triple-negative breast cancer cells.

The LncRNA RMST-miR-4295-ITPR1 axis: a key mechanism in regulating autophagy in triple-negative breast cancer cells.

Journal: BMC cancer

Published: March 05, 2025

Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.

Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.

Journal: Breast cancer research : BCR

Published: December 04, 2024

Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.

Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 10, 2024

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy.

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy.

Journal: International journal of general medicine

Published: June 14, 2023

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study.

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study.

Journal: Frontiers in oncology

Published: April 22, 2023

PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy.

PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy.

Journal: Frontiers in genetics

Published: October 16, 2022

Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis.

Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis.

Journal: Scientific reports

Published: March 22, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026